中国生物医学工程学会在北京举办「第 44 期全国关节镜临床手术操作学习班」。参加学习者将授予国家级 I 类医学继续教育学分。现将有关事项通知如下： 前 43 期已参加学员对学习班的评价：学员甲：收获很大、没有白来！学员乙：学完回去我就敢手术操作了！我们对往期学员的回访跟踪，有部分学员在半年内已经可以完成

国家级继续医学教育项目，项目编号 J43-17-24（国）主办单位：中国医学科学院阜外医院论坛主席：吕滨教授培训班简介：影像检查在心血管疾病诊断中扮演重要的角色，为培养心血管影像诊断高级人才，普及相关专业领域新知识，提高新技术规范化应用水平，中国医学科学院阜外医院放射影像科拟于 2017 年 11 月 23～24 日

LHRHa对乳腺癌复发的影响：一项荟萃分析-43LHRHa治疗绝经前激素受体阳性乳腺癌的荟萃分析-44

期望结果-65肺癌的增长主要来自于腺癌-46肺腺癌病理诊断-43lung cancer

SSc最常合并PAH-43不同CTD-ILD类型的发生率-28CTD-ILD预后差于特发性

病史采集-40病史采集-42MESS研究-112病史资料-41病史采集-45病史采集-43不同的年龄组常见病因 -66部分性发作-10

按毒性转归分类-40开普拓所致腹泻的处理原则-68贫血的处理-52骨髓抑制的表现-49消化系统毒性-53不良反应分级标准-43按毒性所致后果分类-41

β内酰胺类-62暴露后处理-110不规范的给药方式不足量抗生素治疗的结果-43氨基糖甙类-61不规范的给药方式给临床带来的危害-38不规范的给药

-35（三）发病机理-36（三）发病机理-38（三）发病机理-43

附件二：上课地点图地址：北京朝阳区姚家园路251号（朝阳体育馆对面）乘车路线：31路 朝阳体育馆下车43、302、412

B超示总胆管扩张-39B超诊断阻塞性黄疸的优点-38MRCP示胆管癌在左肝内扩散-44Dubin-Johnson综合征-25MRCP示胰腺癌双胆管扩张-42PTC-43MRCP示总胆管中胆石-40S腺苷蛋氨酸-66安全性评价与安慰剂组相比没有差异-77常见黄疸病因的鉴别诊断-47促进胆汁分泌药物

地中海贫血患者中，有43%患者在首次T2加权心血管磁共振扫描检查发现明显的铁超负荷，提示患者可能发生心力衰竭和死亡。”Carpenter在采访中说道

八、脱发-195-Fu-81保护性隔离措施-47表阿霉素（表柔比星）-82便秘的原因-43不良反应发生有关的因素 -24常用化疗药物毒性反应-60常用化学药物及其毒副作用的防治-1常见引起过敏反应的

;Fox O1过表达对肝脏脂代谢相关基因mRNA表达的影响-43Fox O1基因沉默对糖代谢的影响-38

ying888362：患者，男性，43岁，有小三阳病史十余年(有家族史，母亲小三阳携带者，其兄和妹也都是小三阳携带者，父亲死于肝癌)。2011-5-15，因腹痛急诊查B超示：肝癌破裂出血。后因失血性休克行肝动脉栓塞，术后查甲胎蛋白示：82ng/ml。2011-6-12，行肝癌切除术+脾脏切除术，术后甲胎蛋白

）抗凝：首选普通肝素，确诊 STEMI 后立即静注 5000U（60～80U/kg），继以 12 U/（kg•h）静滴，溶栓及溶栓后应监测 APTT 或 ACT... 总剂量 ≤ 100 mg）：普通肝素 5000U（60～80U/kg）静注+rt-PA15 mg 静注，随后 0.75 mg/kg 在 30 min 内静滴

分子流行病学再揭示人类复杂疾病遗传因素及其与环境因素相互作用发挥重要作用,为人类疾病的风险评估、预防和个性化治疗提供依据。全基因组关联分析（GWAS）为全面系统研究复杂疾病的遗传因素掀开了新的一页，为我们了解人类复杂疾病的发病机制提供了更多的线索。科学家已经在肥胖、糖尿病、冠心病、阿尔茨海默、乳腺癌、前列腺癌、肺癌、胃癌等一系列复杂疾病中进行了全基因组关联研究并找到疾病相关的易感基因，我国科学家也在银屑病、精神病和冠心病等方面开展了GWAS研究并取得成效。国家科技部最新公布了“常见重大疾病全基因组关联分析和药物基因组学研究”的863重点项目，吹响了我国大规模开展GWAS研究的号角。为了让更多的相关研究人员，特别是广大研究生了解GWAS的研究原理和方法，学会设计GWAS的研究和分析实验结果，同时在癌症领域分享海内外研究专家们的成功经验，并期待在GWAS方面进行交流合作,复旦大学和美国Van Andel 研究所将于2009年7月12-14日在上海联合举办上海分子流行病学与GWAS国际 研讨会, 期待各位同道免费参加，请有意者及时将回执返回联系邮箱。免注册费（食宿餐饮费用自理）。名额有限，报名从速！时间： 2009年7月12－14日
报到地点： 复旦大学卿云楼宾馆 上海市邯郸路220号，200433
会议地点： 复旦大学逸夫楼报告厅
联 系 人： 赵雪莹 高歌 联系电话： 021-55664495
回执邮箱： GWAS2009@gmail.com
BackgroundRecent success of genome-wide association studies (GWAS) in the U.S. and Europe has lead to the identification of a large number of genetic variants that are associated with disease risk and progression, including those for cancer and cardiovascular diseases. The discovery of these genetic markers not only improves our understanding of disease etiology, but also contributes significantly to risk prediction, early detection, and targeted treatment of diseases.Although GWAS have been used in Chinese populations to identify Chinese-specific risk-associated genetic variants for several common diseases such as breast cancer and psoriasis, many more GWAS are needed for various diseases. A better understanding of the importance of GWAS and a better knowledge of study design and data analysis of GWAS will further promote broad application of GWAS in China. This symposium which will cover genetic epidemiology and GWAS in China is organized to serve this purpose. We have invited a group of experts in this area from the U.S. and China to share their experience in GWAS, and we hope to foster an environment which will encourage an open discussion among all participants.
Objectives• To better understand the potential applications of GWAS
• To address practical issues in study design, implementation, and data analysis of GWAS
• To promote interaction and collaboration among researchers who are interested in GWAS
• To explore other important studies after GWAS: gene-environment interaction, risk prediction, and functional analyses
• To consider issues and implications related to genomic and personalize medicine
Organizing committeeThe organizing committee consists of four members:
Dr. Jianfeng Xu (Co-Chair)
Dr. Daru Lu (Co-Chair)
Dr. Li Jin (Co-Chair ,Advisor)
Dr. Qingyi Wei (Co-Chair, Advisor)
PresentationsSession I: Genetic epidemiology and GWAS of cancer
• Breast cancer in Chinese populations Xiao-ou Shu
• Genetic association studies of skin cancer Jiali Han
• Genetic variants in the MC1R gene and risk of cutaneous melanoma Qingyi Wei
• Genetic association studies of lung cancer in Chinese populations Daru Lu
• Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao Zhou
• Molecular epidemiology of stomach cancer Weimin YeSession II: Genetic epidemiology and GWAS of other diseases
• Genetic association studies of hypertension in Chinese populations Jiang He
• GWAS of Autoimmune Diseases (Psoriasis, etc.) in Chinese populations Wei Huang
• Molecular epidemiology of diabetes in Chinese populations Weiping Jia
• Molecular genetics study of hypertension in Chinese populations Dingliang Zhu
• Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao ZhouSession III: Post-GWAS studies
• Genetic structure of Chinese population Li Jin
• High-throughput genotyping for GWAS and fine mapping studies Siqun Lilly Zheng
• Molecular genetics study of neural tube defect Hongyan Wang
• Risk prediction using genetic variants in prostate cancer Jianfeng Xu
• Gene-environmental interaction in smoking related cancer Zuo-Feng Zhang
• Cancer Somatic Genomics Bin TehSession IV: Short presentations by participants and discussion
Registration时　　间： 2009年7月12－14日
报到地点： 复旦大学卿云楼宾馆大厅 上海市邯郸路220号 (200433)
会议地点： 复旦大学逸夫楼报告厅
联 系 人： 赵雪莹，高歌 (Shanghai, China)；Tamara Adams (U.S.)
联系电话： 21-55664495 (Shanghai, China)；336-713-7532 (U.S.)
回执邮箱： GWAS2009@gmail.com (Shanghai, China)；tsadams@wfubmc.edu (U.S.)
Invited speakers (alphabetic)• Jiali Han, Ph.D., is an Assistant Professor of Medicine at Harvard Medical School. His major research areas are:
• Genetic epidemiology of skin cancer and breast cancer
• Genome-wide association studies
• Gene-environment interaction• Jiang He, M.D. Ph.D., is a Professor and Chair of Epidemiology, Tulane University School of Public Health., U.S.A. His major research areas are:
• Genetic epidemiology of hypertension
• Gene-nutrition interaction of cardiovascular disease• Wei Huang, Ph.D., is a Professor and Executive Deputy Director of Chinese National Human Genome Center at Shanghai, China. Her major research areas are:
• Genetic susceptibility to autoimmune diseases, cardiovascular diseases and cancer.
• Genome-wide association studies
• Genetic variants and association study• Weiping Jia M.D., is a professor of endocrinology at Shanghai Institute of Diabetes, Shanghai No.6 People’s Hospital, Shanghai Jiaotong University, Her major research area is:
• Molecular endocrinology and diabetes• Li Jin, Ph.D, is a Professor of Genetics and vice President of Fudan University, China. His major research areas are:
• Genetic and molecular epidemiology of lung cancer and glioma
• Genetics of metabolism diseases
• Genetic markers for population genetics• Daru Lu, Ph.D, is a Professor of Genetics and Vice Dean of School of Life Sciences, Fudan University, China. His major research areas are:
• Genetic and molecular epidemiology of lung cancer and glioma
• Genetics of metabolic disease• Xiao-ou Shu, M.D, Ph,D, is a Professor of Medicine in the Department of Medicine at the Vanderbilt University School of Medicine, U.S.A. Her major research areas are:
• Genetic and lifestyle predictors of cancer and other chronic diseases
• Cohort study methodology
• Incorporating biomarkers in risk prediction• Bin Teh, M.D, is a Distinguished Scientific Investigator at Van Andel Institute, U.S.A. His major research areas are:
• Translational cancer research
• Gene expression profiling
• Cancer genome high-throughput sequencing• Hongyan Wang, Ph.D, is a professor of genetics at School of Life sciences, Fudan University, China. Her major research area is:
• Molecular genetics and epidemiology of birth defects (deformity of neural tube, congenital heart disease, etc.)• Qingyi Wei, M.D, Ph.D, is a Professor of Epidemiology at The University of Texas M. D. Anderson Cancer Center, U.S.A. His major research areas are:
• Molecular epidemiology of DNA repair, apoptosis, and skin cancer and head and neck cancer
• Genetic susceptibility to cancer
• DNA repair and apoptosis phenotype markers• Jianfeng Xu, M.D, Dr.PH, is a Professor of Epidemiology and Cancer Biology and Director of the Center for Cancer Genomics at Wake Forest University School of Medicine, U.S.A. His major research areas are:
• Genetic epidemiology of prostate cancer
• Genome-wide association and fine mapping analysis
• Risk prediction using genetic markers and other clinicopathologic variables• Zuo-Feng Zhang, M.D., Ph.D, is a Professor of Epidemiology at UCLA School of Public Health, U.S.A. His major research areas are:
• Molecular epidemiology of smoking-related cancers
• Confirmation studies of SNPs identified in genome-wide association studies in smoking-related cancers
• Gene-environmental interaction between genetic markers and environmental factors• S. Lilly Zheng, M.D, is a Professor of Medicine and Director of the Genotyping Laboratory at Wake Forest University School of Medicine. U.S.A. Her major research areas are:
• High-throughput genotyping and sequencing
• Genetic epidemiology of prostate cancer• Gangqiao Zhou, Ph.D, is a Professor of Medical Genetics and Genomics in National Academy of Military Medical Science. His major research area is:
• molecular and genetics of complex diseases• Dingliang Zhu, M.D, is a professor of cardiology at Shanghai Institute of Hypertension, Shanghai, China. His major research area is:
• Molecular and genetics of cardiovascular diseases• Weimin Ye, Ph.D, is a Professor of Medical Epidemiology at Karolinska Institutet, Sweden. His major research areas are: Etiology of upper gastrointestinal diseases
• Topic of presentation: Molecular epidemiology of stomach cancer

自然科学基金条例》（简称《条例》），国家自然科学基金委员会（简称基金委）政策局局长韩宇有点唏嘘。《条例》共计7章43条。“其最大的特点就是

的传染病，中国科协第43期新观点新学说学术沙龙将主题确定为“传染病的遗传易感性”。由中国麻风病控制中心常务副主任、中国麻风病防治协会会长